FDA issued a Warning Letter to Lonza Biologics, Inc. on 9/1/2011 for a previous inspection.
483 Lonza Biologics May 2013

483 Lonza Biologics May 2013

Helen Ricalde FDA$119.00 - Available Now

FDA investigators audited the Lonza Biologics - Hopkinton, MA, United States facility and issued inspectional observations (via FDA 483) on 02 May 2013.

Product details

  • Category: Biologics
  • Inspection end: 02 May 2013
  • Location: Hopkinton, United States
  • FEI: 3001701602
Add To Cart